Benzinga's Top #PreMarket Gainers

By: via Benzinga
ImmunoGen, Inc. (NASDAQ: IMGN) shares gained 18.28% to $8.80 in the pre-market trading session following the announcement of Takeda ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.